William Blair Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.9M Buy
989,687
+199,262
+25% +$7.38M 0.11% 180
2025
Q4
$33.3M Buy
790,425
+112,516
+17% +$4.54M 0.09% 186
2025
Q3
$23.3M Buy
+677,909
New +$19.4M 0.06% 273
2024
Q4
Sell
-811,792
Closed -$27.6M 457
2024
Q3
$27.6M Sell
811,792
-429,879
-35% -$12.1M 0.07% 256
2024
Q2
$26.9M Buy
1,241,671
+500,020
+67% +$10.5M 0.07% 251
2024
Q1
$16.4M Buy
741,651
+6,574
+0.9% +$160K 0.04% 310
2023
Q4
$20.2M Buy
735,077
+104,946
+17% +$2.53M 0.06% 290
2023
Q3
$14.1M Buy
630,131
+18,610
+3% +$479K 0.05% 304
2023
Q2
$15.6M Buy
611,521
+5,713
+0.9% +$138K 0.05% 299
2023
Q1
$13.5M Buy
605,808
+47,424
+8% +$1.15M 0.05% 304
2022
Q4
$13.3M Buy
558,384
+4,705
+0.8% +$109K 0.05% 297
2022
Q3
$9.19M Buy
553,679
+27,636
+5% +$622K 0.04% 309
2022
Q2
$10.5M Sell
526,043
-2,914,833
-85% -$58.9M 0.04% 307
2022
Q1
$94.9M Sell
3,440,876
-502,197
-13% -$14.4M 0.28% 109
2021
Q4
$162M Sell
3,943,073
-53,139
-1% -$2.35M 0.44% 81
2021
Q3
$186M Sell
3,996,212
-42,629
-1% -$1.86M 0.52% 63
2021
Q2
$161M Sell
4,038,841
-556,761
-12% -$23.8M 0.51% 82
2021
Q1
$247M Sell
4,595,602
-612,337
-12% -$35.3M 0.8% 35
2020
Q4
$255M Sell
5,207,939
-473,150
-8% -$21.9M 0.85% 31
2020
Q3
$185M Buy
5,681,089
+1,383,013
+32% +$44M 0.72% 46
2020
Q2
$111M Sell
4,298,076
-158,935
-4% -$3.96M 0.45% 85
2020
Q1
$108M Buy
4,457,011
+887,610
+25% +$22.3M 0.53% 60
2019
Q4
$99.7M Buy
3,569,401
+641,706
+22% +$16.6M 0.4% 86
2019
Q3
$70.3M Buy
2,927,695
+2,200,038
+302% +$58.5M 0.3% 95
2019
Q2
$20.7M Buy
727,657
+252,540
+53% +$6.31M 0.09% 195
2019
Q1
$11.9M Buy
+475,117
New +$9.07M 0.05% 305

Other funds holding VCYT

William Blair Investment Management's VCYT Position: Q1 2026 in Review

William Blair Investment Management increased its Veracyte (VCYT) stake by 25% in Q1 2026, buying an estimated $7.38M and bringing the position to 989,687 shares worth $31.9M. The position accounts for 0.11% of the portfolio, ranked #180.

William Blair Investment Management first reported a position in VCYT in Q1 2019 and has held it in 26 quarters since. The position peaked at $255M in Q4 2020. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • William Blair Investment Management held 989,687 shares of Veracyte worth $31.9M as of Q1 2026.
  • William Blair Investment Management bought 199,262 Veracyte shares in Q1 2026, an estimated $7.38M.
  • Veracyte made up 0.11% of William Blair Investment Management's portfolio in Q1 2026, its #180 holding.
  • William Blair Investment Management first reported a position in Veracyte in Q1 2019 and has held it in 26 quarters since.
  • William Blair Investment Management's Veracyte position peaked at $255M in Q4 2020.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.